• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 29, 2010 - April 2, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 29, 2010 - April 2, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/30/10-
3/31/10
Washington, DCLawrence Deyton, Kathleen Quinn, Amy Hertz, Kim Elliott, Cristi Stark, Thomas GrahamJonathan Samet (University of Southern California); Neal Benowitz (University of California, San Francisco); Mark Clanton (American Cancer Society); Gregory Connolly (Harvard School of Public Health); Karen DeLeeuw (Colorado Department of Public Health and Environment); Jack Henningfield (Pinney Associates); Dorothy Hatsukami (University of Minnesota); Jonathan Heck (A.W. Spears Research Center); Patricia Henderson (Black Hills Center for American Indian Health); John Lauterbach (Lauterbach & Associates); Melanie Wakefield (The Cancer Council Victoria)Speech at Tobacco Products Scientific Advisory Committee
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/31/10Washington, DCJoshua Sharfstein, Michael R. Taylor, Jessica Leighton, Jeff Farrar, Lawrence Deyton, Kim Elliott, Kristy Moran, Josephine TropeaThomas Frieden, Ursula Bauer, Eric Sampson, Rima Khabazz, Jennifer Meunier (Centers for Disease Control and Prevention)Nutrition, Food Safety, and Tobacco
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs4/1/10Silver Spring, MDMary Ann Slack, Randy Levin, Paul Loebach, Gregg Claycamp, Lonnie Smith, Dave Roeder, Jeff O’Neill Thomas R. Bizzaro (First DataBank); Darren K. Townzen (Wal-Mart Stores Inc); Kay Morgan (Gold Standard); John Klimek (National Council for Prescription Drug Programs); Gerald McEvoy (American Society of Health-System Pharmacists); Bill Langlois (Primus Pharmaceuticals); Patricia Milazzo (CVS Caremark) Public Access to FDA Drug Information
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs4/1/10Baltimore, MDN/AAttendees of the 2010 Urban Child SymposiumChallenges and Stresses for the Urban Child
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings 
Beth Martino, Associate Commissioner for External Affairs3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/1/10Silver Spring, MDCathy Norcio, Maggie Dietrich, Ron Yustein, Ellen Pinnow, Daniel Carlos, Danica Marinac-DabicMelvin Hawkins, Tom Connughton, Neal Fearnot, Saralgn Mark, Dexter Elkins, Jennifer Kerr, Charles Mochtosh, Steve Ferguson (Cook Group)Medical Devices
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/1/10TeleconferenceN/AMark McClellan (Engelberg for Health Care Reform, Brookings Institute)Regulatory Science
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/2/10TeleconferenceN/AEmil D. Kakkis, Debra R. Lappin (Kakkis EveryLife Foundation)Biochemical and Genetic Diseases
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/31/10Rockville, MDN/AGigi Hirsch, Ken Oye (MIT's Center for Biomedical Innovation)International Issues
Ralph Tyler, J.D., Chief Counsel3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings 
Russell Abbott, Deputy Commissioner for Administration3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/29/10-
4/2/10
N/AN/AN/ANo Significant Meetings